newsfilter
← Latest News
Business Wire·

PharmaCyte Biotech Rebukes Iroquois' Commencement of Consent Solicitation

- 7% owner Attempting to Take Control of Company Without Paying a Control Premium to Shareholders - Circumvents Proper Vetting of Directors; Proposes Slate with Multiple Connections and Allegiances to Iroquois with History of Value Destruction - P